Results 131 to 140 of about 35,982 (205)

Genomic characterization of XDR Mycobacterium tuberculosis isolates in Argentina (2006-2015). [PDF]

BMC Infect Dis
Castello FA, Sosa EJ, Campos J, Monteserin J, Poklepovich T, Palumbo MC, Serral F, Messano J, García LG, Simboli N, Turjanski A, Paul R, López B, Matteo M, Palomino MM, Martí M, Fernández Do Porto D.   +16 more
europepmc   +1 more source

Correction: Assessing the propensity of TB clinical isolates to form viable but non-replicating subpopulations. [PDF]

Sci Rep
Coetzee JL, Kriel NL, Loubser J, Dippenaar A, Sampson SL, Malherbe ST, Mouton JM.   +6 more
europepmc   +1 more source

Reply to Wilson <i>et al.</i>: The 4-Month Isoniazid, Rifapentine, Moxifloxacin, and Pyrazinamide Treatment Regimen for Drug-Susceptible Pulmonary Tuberculosis: A Word of Caution. [PDF]

Am J Respir Crit Care Med
Saukkonen J, Munsiff S, Winston C, Duarte R, Mammen M.   +4 more
europepmc   +1 more source

Case Report: Co-infection of tuberculosis and pertussis in a 47-day-old infant and therapeutic strategies. [PDF]

Front Pediatr
Tang Q, Li R, Yang X, Wang Y, Luo Y.
europepmc   +1 more source

Establishing translational performance standards for TB therapy using rifampicin-based regimens in a male and female high-burden murine model. [PDF]

BMC Microbiol
Cummings JE, Woolhiser L, Graham B, Robertson GT, Islam MN, Slayden RA.   +5 more
europepmc   +1 more source

Laryngeal <i>Mycobacterium bovis</i>: A Unique Cause of Airway Compromise in a 27-Year-Old Male With Down Syndrome. [PDF]

Case Rep Otolaryngol
Mills MD, Oca M, Don M, Vahabzadeh-Hagh AM.   +3 more
europepmc   +1 more source

Predicting pyrazinamide resistance in Mycobacterium tuberculosis using a graph convolutional network

Dissanayake D, Morrone JA, Fowler PW.
europepmc   +1 more source

Congenital Tuberculous Lymphadenitis in a Preterm Neonate Born to a Comatose Mother in a High TB-Burden Setting: A Case Report. [PDF]

Case Rep Pediatr
Kikuhe JN, Kalere EM, Makata CM, Songya JK.   +3 more
europepmc   +1 more source

¹H/¹⁵N NMR and Low-Field ¹H MRI of SABRE-Hyperpolarized Pyrazinamide─An Approved Antibiotic and Potential MRI Contrast Agent. [PDF]

J Phys Chem B
Siraj Z, Petrilla AF, Senanayake IM, Iqbal N, Gyesi JN, Westerfield J, Daluwathumullagamage PJ, Shchepin RV, Ragunathan S, Chekmenev EY, Goodson BM.   +10 more
europepmc   +1 more source

Pyrazinamide.

Indian pediatrics, 1993
V, Singh, P, Choudhury, R K, Puri
openaire   +1 more source